{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:58:08Z","timestamp":1785560288143,"version":"3.56.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tibtech.2026.07.003","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:17:05Z","timestamp":1785557825000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Affinity chromatography in vaccine manufacturing: from capture technology to quality-defining bioprocessing"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7445-3086","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"B\u00fclb\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ate\u015f","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Denizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.07.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464851","article-title":"Affinity chromatography for virus-like particle manufacturing: challenges, solutions, and perspectives","volume":"1721","author":"Ma","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.963023","article-title":"A platform technology for generating subunit vaccines against diverse viral pathogens","volume":"13","author":"Young","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0015","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1002\/bit.27724","article-title":"Development of a platform process for the production and purification of single-domain antibodies","volume":"118","author":"Crowell","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/bit.29006","article-title":"Integrating affinity chromatography in the platform process for adenovirus purification","volume":"122","author":"Wu","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400526","article-title":"Towards a platform chromatography purification process for adeno-associated virus (AAV)","volume":"20","author":"Bogdanovic","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00604-025-06980-x","article-title":"Biomimetic separations in chemistry and life sciences","volume":"192","author":"Tsopelas","year":"2025","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0035","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1016\/j.vaccine.2018.02.090","article-title":"Affinity chromatography for vaccines manufacturing: finally ready for prime time?","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0040","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/bit.28199","article-title":"Development of versatile affinity-based system for one step purification process: case of Group A Streptococcus vaccine","volume":"119","author":"Chevrel","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800397","article-title":"Affinity chromatography: an enabling technology for large-scale bioprocessing","volume":"15","author":"\u0141\u0105cki","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0050","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/bit.28457","article-title":"Advances in high-throughput, high-capacity nonwoven membranes for chromatography in downstream processing: a review","volume":"121","author":"Lavoie","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00216-022-04325-8","article-title":"Recent development and application of membrane chromatography","volume":"415","author":"Chen","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0060","doi-asserted-by":"crossref","first-page":"19759","DOI":"10.1021\/acs.iecr.5c01289","article-title":"Functional porous materials for biomolecule purification and separation: advances in biotechnological applications","volume":"64","author":"Kip","year":"2025","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2026.138432","article-title":"Non-infectious particle removal in lentiviral vector purification: a path to higher quality","volume":"400","author":"Fernandes","year":"2026","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0070","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1038\/s41467-025-63084-z","article-title":"Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-025-01169-y","article-title":"Accelerating the manufacturing of HIV Env protein vaccines for early phase clinical evaluation","volume":"10","author":"Pensiero","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0080","article-title":"Challenges in downstream purification of gene therapy viral vectors","volume":"33","author":"Singh","year":"2021","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0085","series-title":"Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (Atmps)","year":"2023"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0090","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/bit.27803","article-title":"Downstream processing for influenza vaccines and candidates: an update","volume":"118","author":"Carvalho","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0095","article-title":"Intensified downstream processing of monoclonal antibodies using membrane technology","volume":"16","author":"Nadar","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0100","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/bit.28703","article-title":"Vaccine process technology\u2014a decade of progress","volume":"121","author":"Buckland","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137059","article-title":"Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants","volume":"283","author":"Ma","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465396","article-title":"Peptide ligands for the affinity purification of adenovirus from HEK293 and Vero cell lysates","volume":"1736","author":"Wu","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465320","article-title":"Serotype-agnostic affinity purification of adeno-associated virus (AAV) via peptide-functionalized chromatographic resins","volume":"1734","author":"Shastry","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0120","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/bit.28495","article-title":"Peptide ligands for the affinity purification of adeno-associated viruses from HEK 293 cell lysates","volume":"120","author":"Chu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0125","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.3390\/molecules28176358","article-title":"Interface-based design of high-affinity affibody ligands for the purification of RBD from spike proteins","volume":"28","author":"Song","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.149749","article-title":"Modification of a SARS-CoV-2 spike-RBD targeting nanobody for pH-dependent binding and its chromatographic engineering for purification of WT and variant S-RBDs with mild elution conditions","volume":"338","author":"Zhang","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0135","article-title":"Purification of SARS-CoV-2 RBD in affinity chromatography using a novel nanobody ligand","author":"Zhu","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2024.106638","article-title":"Efficient development of nanobody-based affinity chromatography for AAV8 purification","volume":"227","author":"Li","year":"2025","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464508","article-title":"A specific nanobody-based affinity chromatography resin as a platform for small ubiquitin-related modifier fusion protein purification","volume":"1713","author":"Huang","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/acs.biochem.2c00241","article-title":"Simplified purification of glycoprotein-modified ferritin nanoparticles for vaccine development","volume":"62","author":"Weidenbacher","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0155","first-page":"9","article-title":"Advancing vaccine development with novel chromatography solutions","volume":"21","author":"Sikka","year":"2023","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1193454","article-title":"Glutathione affinity chromatography for the scalable purification of an oncolytic virus immunotherapy from microcarrier cell culture","volume":"11","author":"Swartz","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41541-023-00696-w","article-title":"Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens","volume":"8","author":"Martin","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0170","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/vaccines11091420","article-title":"A subunit vaccine candidate composed of mpox virus A29L, M1R, A35R, and B6R elicits robust immune response in mice","volume":"11","author":"Yang","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/15321819.2024.2376034","article-title":"Molecular dynamics simulation and purification of chimeric L1\/L2 protein from human papillomavirus type 52 expressed in Escherichia coli BL21 (DE3)","volume":"45","author":"Al Adawiah","year":"2024","journal-title":"J. Immunoassay. Immunochem."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49665-2","article-title":"A potent subset of Mycobacterium tuberculosis glycoproteins as relevant candidates for vaccine and therapeutic target","volume":"13","author":"Yari","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12917-022-03471-6","article-title":"Development of gold immunochromatographic assay strip based on specific polyclonal antibodies against capsid protein for rapid detection of porcine circovirus 2 in Zhejiang province, China","volume":"18","author":"Ding","year":"2022","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0190","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s12033-025-01409-5","article-title":"An engineered SARS-CoV-2 S1 glycoprotein produced in Pichia pastoris as a candidate vaccine antigen","volume":"68","author":"Majidi","year":"2026","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2026.106889","article-title":"Scalable production and characterization of recombinant pneumococcal histidine triad protein D in Escherichia coli for vaccine development","volume":"240","author":"Jadhav","year":"2026","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12934-023-02081-7","article-title":"Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography","volume":"22","author":"Carratal\u00e1","year":"2023","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127500","article-title":"Purification and functional characterization of gag-spike virus-like particles: process optimization for efficient vaccine production","volume":"62","author":"Gashti","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vaccine.2023.11.048","article-title":"Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components","volume":"42","author":"Gashti","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0215","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/bit.28419","article-title":"Downstream process design for Gag HIV-1 based virus-like particles","volume":"120","author":"Lorenzo","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0220","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1016\/j.vaccine.2021.10.045","article-title":"Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate","volume":"39","author":"Makovitzki","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/v15030697","article-title":"Efficient purification of cowpea chlorotic mottle virus by a novel peptide aptamer","volume":"15","author":"Tscheuschner","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.procbio.2024.08.022","article-title":"Scalable bioprocess for high-yield production of SARS-CoV-2 trimeric spike protein-based immunogen (IMT-CVAX) using suspension CHO cells","volume":"147","author":"Singh","year":"2024","journal-title":"Process Biochem."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.procbio.2023.03.014","article-title":"Process development of a SARS-CoV-2 nanoparticle vaccine","volume":"129","author":"Martinez-Cano","year":"2023","journal-title":"Process Biochem."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2023.106241","article-title":"A scalable and high yielding SARS-CoV-2 spike protein receptor binding domain production process","volume":"205","author":"Riguero","year":"2023","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2024.127009","article-title":"Capture of fully assembled secretory immunoglobulin A by affinity chromatography with nanobodies as ligands","volume":"343","author":"Ferreira-Faria","year":"2024","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127471","article-title":"Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate","volume":"62","author":"De Mathia","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2021.106013","article-title":"Expression and purification of S5196-272 and S6200317 proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines","volume":"190","author":"Lueangyangyuen","year":"2022","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0260","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11033-021-06727-w","article-title":"Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli","volume":"49","author":"Movahed","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0265","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10826068.2023.2299495","article-title":"Recombinant proteins production in Escherichia coli BL21 for vaccine applications: a cost estimation of potential industrial-scale production scenarios","volume":"54","author":"Akmayan","year":"2024","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trsl.2021.11.009","article-title":"Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials","volume":"242","author":"Whitley","year":"2021","journal-title":"Transl. Res."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0275","series-title":"Good manufacturing practices and upscaling of mRNA vaccine production","first-page":"177","author":"Stamoula","year":"2025"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464670","article-title":"Improved mRNA affinity chromatography binding capacity and throughput using an oligo-dT immobilized electrospun polymer nanofiber adsorbent","volume":"1717","author":"Dewar","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102333","article-title":"Quality by design for mRNA platform purification based on continuous oligo-dT chromatography","volume":"35","author":"Qu","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0290","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/membranes13090770","article-title":"Affinity and pseudo-affinity membrane chromatography for viral vector and vaccine purifications: a review","volume":"13","author":"Lothert","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/gels10030198","article-title":"Cryogels and monoliths: promising tools for chromatographic purification of nucleic acids","volume":"10","author":"Ribeiro","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0300","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/vaccines10081310","article-title":"Membrane chromatography-based downstream processing for cell-culture produced influenza vaccines","volume":"10","author":"Yang","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0305","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41541-025-01218-6","article-title":"Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis","volume":"10","author":"Bale","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0310","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/vaccines13090980","article-title":"GMP manufacturing and characterization of the HIV booster immunogen HxB2.WT.Core-C4b for germline targeting vaccine strategies","volume":"13","author":"Pallerla","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0315","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/vaccines11101602","article-title":"Large-scale purification and characterization of recombinant receptor-binding domain (RBD) of SARS-CoV-2 spike protein expressed in yeast","volume":"11","author":"Nagar","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0320","article-title":"Scalable downstream process of the recombinant RBD from SARS-CoV-2 in Pichia pastoris","volume":"11","author":"Boggiano-Ayo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0325","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12934-021-01583-6","article-title":"Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus","volume":"20","author":"Dalvie","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465937","article-title":"De novo design and discovery of broad-spectrum affinity peptide ligands for influenza A vaccines","volume":"1750","author":"Tian","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0335","article-title":"DOE-based process optimization for development of efficient methods for purification of recombinant hepatitis B surface antigen from Pichia pastoris feedstock using Capto adhere resin","volume":"10","author":"Goodarzi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124122","article-title":"High purity and recovery of native filamentous hemagglutinin (FHA) from Bordetella pertussis using affinity chromatography","volume":"1239","author":"Imani","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0345","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jbiotec.2021.10.003","article-title":"Continuous purification of influenza A virus particles using pseudo-affinity membrane chromatography","volume":"342","author":"Fortuna","year":"2021","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465685","article-title":"Broad-spectrum affinity chromatography of SARS-CoV-2 and Omicron vaccines from ligand screening to purification","volume":"1743","author":"Ma","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1021905","article-title":"Current GMP standards for the production of vaccines and antibodies: an overview","volume":"10","author":"Covarrubias","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1658366","article-title":"Residual host cell proteins: sources, properties, detection methods and data acquisition modes","volume":"16","author":"Yao","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0365","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2213365","article-title":"Technical advancement and practical considerations of LC-MS\/MS-based methods for host cell protein identification and quantitation to support process development","volume":"15","author":"Guo","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300068","article-title":"Characterisation of the E. coli HMS174 and BLR host cell proteome to guide purification process development","volume":"18","author":"Disela","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/biotech10040025","article-title":"In-line monitoring of downstream purification processes for VSV-based SARS-CoV-2 vaccine using a novel technique","volume":"10","author":"Makovitzki","year":"2021","journal-title":"BioTech"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0380","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/vaccines9080823","article-title":"Critical assessment of purification and analytical technologies for enveloped viral vector and vaccine processing and their current limitations in resolving co-expressed extracellular vesicles","volume":"9","author":"Do Minh","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2026.466890","article-title":"Protein language model-guided generative design of affinity peptides for chromatographic purification of lentiviral vectors","volume":"1774","author":"Wang","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466577","article-title":"A stable all-D peptide ligand inspires broad-spectrum affinity and high performance in the purification of COVID-19 vaccines","volume":"1766","author":"Ma","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466552","article-title":"Discovery of a broad-spectrum affibody ligand for COVID-19 vaccine purification","volume":"1766","author":"Li","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465785","article-title":"Implementation of a nanobody-liganded affinity resin for improving the production of recombinant HBsAg-VLP in large scale","volume":"1746","author":"Han","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2024.129310","article-title":"Convection rather than diffusion for fast efficient mRNA vaccine purification","volume":"354","author":"Banik","year":"2025","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126951","article-title":"Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2","volume":"53","author":"Kadoi","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2022.122320","article-title":"Development and scale-up of oligo-dT monolithic chromatographic column for mRNA capture through understanding of base-pairing interactions","volume":"304","author":"Mencin","year":"2023","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466610","article-title":"Single-step recovery of mRNA via multimodal chromatography to advance vaccine manufacturing","volume":"1766","author":"Rosa","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0425","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/bit.28096","article-title":"Towards continuous mAb purification: clearance of host cell proteins from CHO cell culture harvests via \u201cflow-through affinity chromatography\u201d using peptide-based adsorbents","volume":"119","author":"Sripada","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465470","article-title":"Highly pure measles virus generated by combination of salt-active nuclease treatment and heparin affinity chromatography","volume":"1738","author":"Mayer","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0435","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acs.jproteome.5c01041","article-title":"Proteomics strategies for mass spectrometry analysis of host cell proteins in monoclonal antibody bioprocessing","volume":"25","author":"Cao","year":"2026","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0440","first-page":"324","article-title":"High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography","volume":"26","author":"Florea","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tibtech.2026.07.003_bb0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12934-021-01514-5","article-title":"Investigation of Kluyveromyces marxianus as a novel host for large-scale production of porcine parvovirus virus-like particles","volume":"20","author":"Yang","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.07.003_bb0450","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.1021\/acs.iecr.2c01217","article-title":"Mobile-on-demand COVID-19 vaccine production units for developing countries","volume":"61","author":"Fahr","year":"2022","journal-title":"Ind. Eng. Chem. Res."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926002829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926002829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:17:16Z","timestamp":1785557836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779926002829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":90,"alternative-id":["S0167779926002829"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.003","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Affinity chromatography in vaccine manufacturing: from capture technology to quality-defining bioprocessing","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}